StonvexLoading…
StonvexStonvexStonvexCore line items from UTZ's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-28 | Annual 2024 2024-12-29 | Annual 2023 2023-12-31 | Annual 2023 2023-01-01 |
|---|---|---|---|---|
Revenue | $1.44B | $1.41B | $1.44B | $1.41B |
Operating Income | $19.50M | $58.90M | $16.00M | $5.34M |
Net Income | $800.00K | $15.90M | $-24.90M | $-392.00K |
EPS (Diluted) | $0.01 | $0.19 | $-0.31 | $0.00 |
Total Assets | $2.79B | $2.72B | $2.75B | $2.84B |
Total Liabilities | $1.45B | $1.34B | $1.36B | $1.39B |
Cash & Equivalents | $120.40M | $56.10M | $52.02M | $72.93M |
Free Cash Flow OCF − CapEx | $9.40M | $7.60M | $20.90M | $-39.77M |
Shares Outstanding | 87.77M | 85.43M | 81.08M | 80.09M |